You just read:

Array BioPharma Announces FDA Acceptance For Review Of Binimetinib And Encorafenib New Drug Applications For Patients With Advanced BRAF-mutant Melanoma

News provided by

Array BioPharma Inc.

Sep 12, 2017, 09:09 ET